MersV1, Ncbi, Merge, bibRecord, 001065

SARS hCoV papain-like protease is a unique Lys48 linkage-specific di-distributive deubiquitinating enzyme.

Identifieur interne : 001065 ( Ncbi/Merge ); précédent : 001064; suivant : 001066

SARS hCoV papain-like protease is a unique Lys48 linkage-specific di-distributive deubiquitinating enzyme.

Auteurs : Mikl S Békés [États-Unis] ; Wioletta Rut [Pologne] ; Paulina Kasperkiewicz [Pologne] ; Monique P C. Mulder [Pays-Bas] ; Huib Ovaa [Pays-Bas] ; Marcin Drag [Pologne] ; Christopher D. Lima [États-Unis] ; Tony T. Huang [États-Unis]

Source :

The Biochemical journal [ 1470-8728 ] ; 2015.

RBID : pubmed:25764917

Descripteurs français

KwdFr :
- Conformation des protéines, Endopeptidases (métabolisme), Humains, Infections à coronavirus (métabolisme), Infections à coronavirus (virologie), Lysine (métabolisme), Maturation post-traductionnelle des protéines, Papaïne (métabolisme), Peptide hydrolases (métabolisme), Protéines virales (métabolisme), Spécificité du substrat, Ubiquitine (métabolisme), Ubiquitinylation, Virus du SRAS (enzymologie).
MESH :
- enzymologie : Virus du SRAS.
- métabolisme : Endopeptidases, Infections à coronavirus, Lysine, Papaïne, Peptide hydrolases, Protéines virales, Ubiquitine.
- virologie : Infections à coronavirus.
- Conformation des protéines, Humains, Maturation post-traductionnelle des protéines, Spécificité du substrat, Ubiquitinylation.

English descriptors

KwdEn :
- Coronavirus Infections (metabolism), Coronavirus Infections (virology), Endopeptidases (metabolism), Humans, Lysine (metabolism), Papain (metabolism), Peptide Hydrolases (metabolism), Protein Conformation, Protein Processing, Post-Translational, SARS Virus (enzymology), Substrate Specificity, Ubiquitin (metabolism), Ubiquitination, Viral Proteins (metabolism).
MESH :
- chemical , metabolism : Endopeptidases, Lysine, Papain, Peptide Hydrolases, Ubiquitin, Viral Proteins.
- enzymology : SARS Virus.
- metabolism : Coronavirus Infections.
- virology : Coronavirus Infections.
- Humans, Protein Conformation, Protein Processing, Post-Translational, Substrate Specificity, Ubiquitination.

Abstract

Ubiquitin (Ub) and the Ub-like (Ubl) modifier interferon-stimulated gene 15 (ISG15) participate in the host defence of viral infections. Viruses, including the severe acute respiratory syndrome human coronavirus (SARS hCoV), have co-opted Ub-ISG15 conjugation pathways for their own advantage or have evolved effector proteins to counter pro-inflammatory properties of Ub-ISG15-conjugated host proteins. In the present study, we compare substrate specificities of the papain-like protease (PLpro) from the recently emerged Middle East respiratory syndrome (MERS) hCoV to the related protease from SARS, SARS PLpro. Through biochemical assays, we show that, similar to SARS PLpro, MERS PLpro is both a deubiquitinating (DUB) and a deISGylating enzyme. Further analysis of the intrinsic DUB activity of these viral proteases revealed unique differences between the recognition and cleavage specificities of polyUb chains. First, MERS PLpro shows broad linkage specificity for the cleavage of polyUb chains, whereas SARS PLpro prefers to cleave Lys48-linked polyUb chains. Secondly, MERS PLpro cleaves polyUb chains in a 'mono-distributive' manner (one Ub at a time) and SARS PLpro prefers to cleave Lys48-linked polyUb chains by sensing a di-Ub moiety as a minimal recognition element using a 'di-distributive' cleavage mechanism. The di-distributive cleavage mechanism for SARS PLpro appears to be uncommon among USP (Ub-specific protease)-family DUBs, as related USP family members from humans do not display such a mechanism. We propose that these intrinsic enzymatic differences between SARS and MERS PLpro will help to identify pro-inflammatory substrates of these viral DUBs and can guide in the design of therapeutics to combat infection by coronaviruses.

DOI: 10.1042/BJ20141170
PubMed: 25764917

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 001676
to stream PubMed, to step Curation: 001676
to stream PubMed, to step Checkpoint: 001356

Links to Exploration step

pubmed:25764917

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">SARS hCoV papain-like protease is a unique Lys48 linkage-specific di-distributive deubiquitinating enzyme.</title>
<author><name sortKey="Bekes, Mikl S" sort="Bekes, Mikl S" uniqKey="Bekes M" first="Mikl S" last="Békés">Mikl S Békés</name>
<affiliation wicri:level="2"><nlm:affiliation>*Department of Biochemistry & Molecular Pharmacology, New York University School of Medicine, New York, NY 10016, U.S.A.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>*Department of Biochemistry & Molecular Pharmacology, New York University School of Medicine, New York, NY 10016</wicri:regionArea>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Rut, Wioletta" sort="Rut, Wioletta" uniqKey="Rut W" first="Wioletta" last="Rut">Wioletta Rut</name>
<affiliation wicri:level="1"><nlm:affiliation>†Division of Bioorganic Chemistry, Faculty of Chemistry, Wroclaw University of Technology, Wyb. Wyspianskiego 27, Wroclaw 50-370, Poland.</nlm:affiliation>
<country xml:lang="fr">Pologne</country>
<wicri:regionArea>†Division of Bioorganic Chemistry, Faculty of Chemistry, Wroclaw University of Technology, Wyb. Wyspianskiego 27, Wroclaw 50-370</wicri:regionArea>
<wicri:noRegion>Wroclaw 50-370</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kasperkiewicz, Paulina" sort="Kasperkiewicz, Paulina" uniqKey="Kasperkiewicz P" first="Paulina" last="Kasperkiewicz">Paulina Kasperkiewicz</name>
<affiliation wicri:level="1"><nlm:affiliation>†Division of Bioorganic Chemistry, Faculty of Chemistry, Wroclaw University of Technology, Wyb. Wyspianskiego 27, Wroclaw 50-370, Poland.</nlm:affiliation>
<country xml:lang="fr">Pologne</country>
<wicri:regionArea>†Division of Bioorganic Chemistry, Faculty of Chemistry, Wroclaw University of Technology, Wyb. Wyspianskiego 27, Wroclaw 50-370</wicri:regionArea>
<wicri:noRegion>Wroclaw 50-370</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Mulder, Monique P C" sort="Mulder, Monique P C" uniqKey="Mulder M" first="Monique P C" last="Mulder">Monique P C. Mulder</name>
<affiliation wicri:level="3"><nlm:affiliation>‡Division of Cell Biology, Netherlands Cancer Institute (NKI), Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>‡Division of Cell Biology, Netherlands Cancer Institute (NKI), Plesmanlaan 121, 1066 CX, Amsterdam</wicri:regionArea>
<placeName><settlement type="city">Amsterdam</settlement>
<region nuts="2" type="province">Hollande-Septentrionale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Ovaa, Huib" sort="Ovaa, Huib" uniqKey="Ovaa H" first="Huib" last="Ovaa">Huib Ovaa</name>
<affiliation wicri:level="3"><nlm:affiliation>‡Division of Cell Biology, Netherlands Cancer Institute (NKI), Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>‡Division of Cell Biology, Netherlands Cancer Institute (NKI), Plesmanlaan 121, 1066 CX, Amsterdam</wicri:regionArea>
<placeName><settlement type="city">Amsterdam</settlement>
<region nuts="2" type="province">Hollande-Septentrionale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Drag, Marcin" sort="Drag, Marcin" uniqKey="Drag M" first="Marcin" last="Drag">Marcin Drag</name>
<affiliation wicri:level="1"><nlm:affiliation>†Division of Bioorganic Chemistry, Faculty of Chemistry, Wroclaw University of Technology, Wyb. Wyspianskiego 27, Wroclaw 50-370, Poland.</nlm:affiliation>
<country xml:lang="fr">Pologne</country>
<wicri:regionArea>†Division of Bioorganic Chemistry, Faculty of Chemistry, Wroclaw University of Technology, Wyb. Wyspianskiego 27, Wroclaw 50-370</wicri:regionArea>
<wicri:noRegion>Wroclaw 50-370</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Lima, Christopher D" sort="Lima, Christopher D" uniqKey="Lima C" first="Christopher D" last="Lima">Christopher D. Lima</name>
<affiliation wicri:level="2"><nlm:affiliation>§Structural Biology Program, Sloan-Kettering Institute, 1275 York Ave, New York, NY 10065, U.S.A.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>§Structural Biology Program, Sloan-Kettering Institute, 1275 York Ave, New York, NY 10065</wicri:regionArea>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Huang, Tony T" sort="Huang, Tony T" uniqKey="Huang T" first="Tony T" last="Huang">Tony T. Huang</name>
<affiliation wicri:level="2"><nlm:affiliation>*Department of Biochemistry & Molecular Pharmacology, New York University School of Medicine, New York, NY 10016, U.S.A.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>*Department of Biochemistry & Molecular Pharmacology, New York University School of Medicine, New York, NY 10016</wicri:regionArea>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:25764917</idno>
<idno type="pmid">25764917</idno>
<idno type="doi">10.1042/BJ20141170</idno>
<idno type="wicri:Area/PubMed/Corpus">001676</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001676</idno>
<idno type="wicri:Area/PubMed/Curation">001676</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001676</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001356</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001356</idno>
<idno type="wicri:Area/Ncbi/Merge">001065</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">SARS hCoV papain-like protease is a unique Lys48 linkage-specific di-distributive deubiquitinating enzyme.</title>
<author><name sortKey="Bekes, Mikl S" sort="Bekes, Mikl S" uniqKey="Bekes M" first="Mikl S" last="Békés">Mikl S Békés</name>
<affiliation wicri:level="2"><nlm:affiliation>*Department of Biochemistry & Molecular Pharmacology, New York University School of Medicine, New York, NY 10016, U.S.A.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>*Department of Biochemistry & Molecular Pharmacology, New York University School of Medicine, New York, NY 10016</wicri:regionArea>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Rut, Wioletta" sort="Rut, Wioletta" uniqKey="Rut W" first="Wioletta" last="Rut">Wioletta Rut</name>
<affiliation wicri:level="1"><nlm:affiliation>†Division of Bioorganic Chemistry, Faculty of Chemistry, Wroclaw University of Technology, Wyb. Wyspianskiego 27, Wroclaw 50-370, Poland.</nlm:affiliation>
<country xml:lang="fr">Pologne</country>
<wicri:regionArea>†Division of Bioorganic Chemistry, Faculty of Chemistry, Wroclaw University of Technology, Wyb. Wyspianskiego 27, Wroclaw 50-370</wicri:regionArea>
<wicri:noRegion>Wroclaw 50-370</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kasperkiewicz, Paulina" sort="Kasperkiewicz, Paulina" uniqKey="Kasperkiewicz P" first="Paulina" last="Kasperkiewicz">Paulina Kasperkiewicz</name>
<affiliation wicri:level="1"><nlm:affiliation>†Division of Bioorganic Chemistry, Faculty of Chemistry, Wroclaw University of Technology, Wyb. Wyspianskiego 27, Wroclaw 50-370, Poland.</nlm:affiliation>
<country xml:lang="fr">Pologne</country>
<wicri:regionArea>†Division of Bioorganic Chemistry, Faculty of Chemistry, Wroclaw University of Technology, Wyb. Wyspianskiego 27, Wroclaw 50-370</wicri:regionArea>
<wicri:noRegion>Wroclaw 50-370</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Mulder, Monique P C" sort="Mulder, Monique P C" uniqKey="Mulder M" first="Monique P C" last="Mulder">Monique P C. Mulder</name>
<affiliation wicri:level="3"><nlm:affiliation>‡Division of Cell Biology, Netherlands Cancer Institute (NKI), Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>‡Division of Cell Biology, Netherlands Cancer Institute (NKI), Plesmanlaan 121, 1066 CX, Amsterdam</wicri:regionArea>
<placeName><settlement type="city">Amsterdam</settlement>
<region nuts="2" type="province">Hollande-Septentrionale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Ovaa, Huib" sort="Ovaa, Huib" uniqKey="Ovaa H" first="Huib" last="Ovaa">Huib Ovaa</name>
<affiliation wicri:level="3"><nlm:affiliation>‡Division of Cell Biology, Netherlands Cancer Institute (NKI), Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>‡Division of Cell Biology, Netherlands Cancer Institute (NKI), Plesmanlaan 121, 1066 CX, Amsterdam</wicri:regionArea>
<placeName><settlement type="city">Amsterdam</settlement>
<region nuts="2" type="province">Hollande-Septentrionale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Drag, Marcin" sort="Drag, Marcin" uniqKey="Drag M" first="Marcin" last="Drag">Marcin Drag</name>
<affiliation wicri:level="1"><nlm:affiliation>†Division of Bioorganic Chemistry, Faculty of Chemistry, Wroclaw University of Technology, Wyb. Wyspianskiego 27, Wroclaw 50-370, Poland.</nlm:affiliation>
<country xml:lang="fr">Pologne</country>
<wicri:regionArea>†Division of Bioorganic Chemistry, Faculty of Chemistry, Wroclaw University of Technology, Wyb. Wyspianskiego 27, Wroclaw 50-370</wicri:regionArea>
<wicri:noRegion>Wroclaw 50-370</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Lima, Christopher D" sort="Lima, Christopher D" uniqKey="Lima C" first="Christopher D" last="Lima">Christopher D. Lima</name>
<affiliation wicri:level="2"><nlm:affiliation>§Structural Biology Program, Sloan-Kettering Institute, 1275 York Ave, New York, NY 10065, U.S.A.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>§Structural Biology Program, Sloan-Kettering Institute, 1275 York Ave, New York, NY 10065</wicri:regionArea>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Huang, Tony T" sort="Huang, Tony T" uniqKey="Huang T" first="Tony T" last="Huang">Tony T. Huang</name>
<affiliation wicri:level="2"><nlm:affiliation>*Department of Biochemistry & Molecular Pharmacology, New York University School of Medicine, New York, NY 10016, U.S.A.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>*Department of Biochemistry & Molecular Pharmacology, New York University School of Medicine, New York, NY 10016</wicri:regionArea>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">The Biochemical journal</title>
<idno type="eISSN">1470-8728</idno>
<imprint><date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Coronavirus Infections (metabolism)</term>
<term>Coronavirus Infections (virology)</term>
<term>Endopeptidases (metabolism)</term>
<term>Humans</term>
<term>Lysine (metabolism)</term>
<term>Papain (metabolism)</term>
<term>Peptide Hydrolases (metabolism)</term>
<term>Protein Conformation</term>
<term>Protein Processing, Post-Translational</term>
<term>SARS Virus (enzymology)</term>
<term>Substrate Specificity</term>
<term>Ubiquitin (metabolism)</term>
<term>Ubiquitination</term>
<term>Viral Proteins (metabolism)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Conformation des protéines</term>
<term>Endopeptidases (métabolisme)</term>
<term>Humains</term>
<term>Infections à coronavirus (métabolisme)</term>
<term>Infections à coronavirus (virologie)</term>
<term>Lysine (métabolisme)</term>
<term>Maturation post-traductionnelle des protéines</term>
<term>Papaïne (métabolisme)</term>
<term>Peptide hydrolases (métabolisme)</term>
<term>Protéines virales (métabolisme)</term>
<term>Spécificité du substrat</term>
<term>Ubiquitine (métabolisme)</term>
<term>Ubiquitinylation</term>
<term>Virus du SRAS (enzymologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Endopeptidases</term>
<term>Lysine</term>
<term>Papain</term>
<term>Peptide Hydrolases</term>
<term>Ubiquitin</term>
<term>Viral Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymologie" xml:lang="fr"><term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymology" xml:lang="en"><term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Coronavirus Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Endopeptidases</term>
<term>Infections à coronavirus</term>
<term>Lysine</term>
<term>Papaïne</term>
<term>Peptide hydrolases</term>
<term>Protéines virales</term>
<term>Ubiquitine</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Infections à coronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Coronavirus Infections</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
<term>Protein Conformation</term>
<term>Protein Processing, Post-Translational</term>
<term>Substrate Specificity</term>
<term>Ubiquitination</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Conformation des protéines</term>
<term>Humains</term>
<term>Maturation post-traductionnelle des protéines</term>
<term>Spécificité du substrat</term>
<term>Ubiquitinylation</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Ubiquitin (Ub) and the Ub-like (Ubl) modifier interferon-stimulated gene 15 (ISG15) participate in the host defence of viral infections. Viruses, including the severe acute respiratory syndrome human coronavirus (SARS hCoV), have co-opted Ub-ISG15 conjugation pathways for their own advantage or have evolved effector proteins to counter pro-inflammatory properties of Ub-ISG15-conjugated host proteins. In the present study, we compare substrate specificities of the papain-like protease (PLpro) from the recently emerged Middle East respiratory syndrome (MERS) hCoV to the related protease from SARS, SARS PLpro. Through biochemical assays, we show that, similar to SARS PLpro, MERS PLpro is both a deubiquitinating (DUB) and a deISGylating enzyme. Further analysis of the intrinsic DUB activity of these viral proteases revealed unique differences between the recognition and cleavage specificities of polyUb chains. First, MERS PLpro shows broad linkage specificity for the cleavage of polyUb chains, whereas SARS PLpro prefers to cleave Lys48-linked polyUb chains. Secondly, MERS PLpro cleaves polyUb chains in a 'mono-distributive' manner (one Ub at a time) and SARS PLpro prefers to cleave Lys48-linked polyUb chains by sensing a di-Ub moiety as a minimal recognition element using a 'di-distributive' cleavage mechanism. The di-distributive cleavage mechanism for SARS PLpro appears to be uncommon among USP (Ub-specific protease)-family DUBs, as related USP family members from humans do not display such a mechanism. We propose that these intrinsic enzymatic differences between SARS and MERS PLpro will help to identify pro-inflammatory substrates of these viral DUBs and can guide in the design of therapeutics to combat infection by coronaviruses. </div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25764917</PMID>
<DateCompleted><Year>2015</Year>
<Month>08</Month>
<Day>04</Day>
</DateCompleted>
<DateRevised><Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1470-8728</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>468</Volume>
<Issue>2</Issue>
<PubDate><Year>2015</Year>
<Month>Jun</Month>
<Day>01</Day>
</PubDate>
</JournalIssue>
<Title>The Biochemical journal</Title>
<ISOAbbreviation>Biochem. J.</ISOAbbreviation>
</Journal>
<ArticleTitle>SARS hCoV papain-like protease is a unique Lys48 linkage-specific di-distributive deubiquitinating enzyme.</ArticleTitle>
<Pagination><MedlinePgn>215-26</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1042/BJ20141170</ELocationID>
<Abstract><AbstractText>Ubiquitin (Ub) and the Ub-like (Ubl) modifier interferon-stimulated gene 15 (ISG15) participate in the host defence of viral infections. Viruses, including the severe acute respiratory syndrome human coronavirus (SARS hCoV), have co-opted Ub-ISG15 conjugation pathways for their own advantage or have evolved effector proteins to counter pro-inflammatory properties of Ub-ISG15-conjugated host proteins. In the present study, we compare substrate specificities of the papain-like protease (PLpro) from the recently emerged Middle East respiratory syndrome (MERS) hCoV to the related protease from SARS, SARS PLpro. Through biochemical assays, we show that, similar to SARS PLpro, MERS PLpro is both a deubiquitinating (DUB) and a deISGylating enzyme. Further analysis of the intrinsic DUB activity of these viral proteases revealed unique differences between the recognition and cleavage specificities of polyUb chains. First, MERS PLpro shows broad linkage specificity for the cleavage of polyUb chains, whereas SARS PLpro prefers to cleave Lys48-linked polyUb chains. Secondly, MERS PLpro cleaves polyUb chains in a 'mono-distributive' manner (one Ub at a time) and SARS PLpro prefers to cleave Lys48-linked polyUb chains by sensing a di-Ub moiety as a minimal recognition element using a 'di-distributive' cleavage mechanism. The di-distributive cleavage mechanism for SARS PLpro appears to be uncommon among USP (Ub-specific protease)-family DUBs, as related USP family members from humans do not display such a mechanism. We propose that these intrinsic enzymatic differences between SARS and MERS PLpro will help to identify pro-inflammatory substrates of these viral DUBs and can guide in the design of therapeutics to combat infection by coronaviruses. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Békés</LastName>
<ForeName>Miklós</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>*Department of Biochemistry & Molecular Pharmacology, New York University School of Medicine, New York, NY 10016, U.S.A.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Rut</LastName>
<ForeName>Wioletta</ForeName>
<Initials>W</Initials>
<AffiliationInfo><Affiliation>†Division of Bioorganic Chemistry, Faculty of Chemistry, Wroclaw University of Technology, Wyb. Wyspianskiego 27, Wroclaw 50-370, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Kasperkiewicz</LastName>
<ForeName>Paulina</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>†Division of Bioorganic Chemistry, Faculty of Chemistry, Wroclaw University of Technology, Wyb. Wyspianskiego 27, Wroclaw 50-370, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Mulder</LastName>
<ForeName>Monique P C</ForeName>
<Initials>MP</Initials>
<AffiliationInfo><Affiliation>‡Division of Cell Biology, Netherlands Cancer Institute (NKI), Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Ovaa</LastName>
<ForeName>Huib</ForeName>
<Initials>H</Initials>
<AffiliationInfo><Affiliation>‡Division of Cell Biology, Netherlands Cancer Institute (NKI), Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Drag</LastName>
<ForeName>Marcin</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>†Division of Bioorganic Chemistry, Faculty of Chemistry, Wroclaw University of Technology, Wyb. Wyspianskiego 27, Wroclaw 50-370, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Lima</LastName>
<ForeName>Christopher D</ForeName>
<Initials>CD</Initials>
<AffiliationInfo><Affiliation>§Structural Biology Program, Sloan-Kettering Institute, 1275 York Ave, New York, NY 10065, U.S.A.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Huang</LastName>
<ForeName>Tony T</ForeName>
<Initials>TT</Initials>
<AffiliationInfo><Affiliation>*Department of Biochemistry & Molecular Pharmacology, New York University School of Medicine, New York, NY 10016, U.S.A.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>R01 GM084244</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R01 GM065872</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>GM065872</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><Agency>Howard Hughes Medical Institute</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>F32 GM100598</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>GM084244</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Biochem J</MedlineTA>
<NlmUniqueID>2984726R</NlmUniqueID>
<ISSNLinking>0264-6021</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D025801">Ubiquitin</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.4.-</RegistryNumber>
<NameOfSubstance UI="D010450">Endopeptidases</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.4.-</RegistryNumber>
<NameOfSubstance UI="D010447">Peptide Hydrolases</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.4.22.2</RegistryNumber>
<NameOfSubstance UI="D010206">Papain</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>K3Z4F929H6</RegistryNumber>
<NameOfSubstance UI="D008239">Lysine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010450" MajorTopicYN="N">Endopeptidases</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008239" MajorTopicYN="N">Lysine</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010206" MajorTopicYN="N">Papain</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010447" MajorTopicYN="N">Peptide Hydrolases</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011487" MajorTopicYN="N">Protein Conformation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011499" MajorTopicYN="N">Protein Processing, Post-Translational</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName>
<QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013379" MajorTopicYN="N">Substrate Specificity</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D025801" MajorTopicYN="N">Ubiquitin</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D054875" MajorTopicYN="N">Ubiquitination</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year>
<Month>3</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2015</Year>
<Month>3</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2015</Year>
<Month>8</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">25764917</ArticleId>
<ArticleId IdType="pii">BJ20141170</ArticleId>
<ArticleId IdType="doi">10.1042/BJ20141170</ArticleId>
<ArticleId IdType="pmc">PMC4447217</ArticleId>
<ArticleId IdType="mid">NIHMS690722</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Virus Res. 2014 Dec 19;194:184-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24512893</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2014 Nov;88(21):12511-27</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25142582</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2008 Oct 21;105(42):16119-24</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18852458</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem J. 2008 Nov 1;415(3):367-75</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18601651</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Antiviral Res. 2015 Mar;115:21-38</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25554382</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Chem Rev. 2009 Apr;109(4):1479-80</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19253968</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2000 May 9;97(10):5516-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10805807</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Annu Rev Biochem. 2001;70:503-33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11395416</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Biophys Res Commun. 1967 Apr 20;27(2):157-62</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6035483</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Annu Rev Biochem. 1998;67:425-79</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9759494</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2005 Jul 22;280(29):27356-65</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15917233</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2005 Dec;79(24):15189-98</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16306590</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Structure. 2006 Aug;14(8):1293-302</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16905103</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arch Biochem Biophys. 2007 Oct 1;466(1):8-14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17692280</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem J. 2008 Jan 15;409(2):461-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17916063</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Protein Sci. 2008 Jun;17(6):1035-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18424514</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2008 Sep 26;283(39):26436-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18599482</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>EMBO Rep. 2009 May;10(5):466-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19373254</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Annu Rev Biochem. 2009;78:363-97</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19489724</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Host Microbe. 2009 Jun 18;5(6):559-70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19527883</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Mol Cell Biol. 2009 Aug;10(8):550-63</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19626045</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2010 May;84(9):4619-29</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20181693</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Cell. 2010 Jun 11;38(5):722-32</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20542004</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell. 2010 Oct 15;143(2):187-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20946978</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Chem Biol. 2011 Dec 23;18(12):1550-61</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22195557</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Methods Mol Biol. 2012;832:141-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22350882</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Annu Rev Biochem. 2012;81:203-29</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22524316</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Euro Surveill. 2012;17(39). pii: 20282</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23041021</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>MBio. 2012;3(6). pii: e00473-12. doi: 10.1128/mBio.00473-12</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23170002</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2012 Dec 13;492(7428):266-70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23201676</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell. 2013 Jul 3;154(1):169-84</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23827681</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>MBio. 2013;4(5):e00650-13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24023385</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Infect Dis. 2013 Oct;13(10):859-66</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23933067</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Rep. 2013 Nov 14;5(3):826-38</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24210823</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Antiviral Res. 2013 Oct;100(1):286-95</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24012996</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Chem Commun (Camb). 2014 Jan 7;50(2):216-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24225431</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Antiviral Res. 2014 Jan;101:45-56</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24184128</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virology. 2014 Feb;450-451:64-70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24503068</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Gen Virol. 2014 Mar;95(Pt 3):614-26</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24362959</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2014 Feb 18;111(7):2518-23</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24550277</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Med Chem. 2014 Mar 27;57(6):2393-412</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24568342</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Chembiochem. 2014 May 5;15(7):946-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24623714</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Pathog. 2014 May;10(5):e1004113</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24854014</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Euro Surveill. 2014;19(25). pii: 20840</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24993553</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virus Res. 2014 Aug 30;189:262-70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24930446</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2014 Oct;88(20):11825-33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25100850</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2014 Dec 12;289(50):34667-82</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25320088</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Pays-Bas</li>
<li>Pologne</li>
<li>États-Unis</li>
</country>
<region><li>Hollande-Septentrionale</li>
<li>État de New York</li>
</region>
<settlement><li>Amsterdam</li>
</settlement>
</list>
<tree><country name="États-Unis"><region name="État de New York"><name sortKey="Bekes, Mikl S" sort="Bekes, Mikl S" uniqKey="Bekes M" first="Mikl S" last="Békés">Mikl S Békés</name>
</region>
<name sortKey="Huang, Tony T" sort="Huang, Tony T" uniqKey="Huang T" first="Tony T" last="Huang">Tony T. Huang</name>
<name sortKey="Lima, Christopher D" sort="Lima, Christopher D" uniqKey="Lima C" first="Christopher D" last="Lima">Christopher D. Lima</name>
</country>
<country name="Pologne"><noRegion><name sortKey="Rut, Wioletta" sort="Rut, Wioletta" uniqKey="Rut W" first="Wioletta" last="Rut">Wioletta Rut</name>
</noRegion>
<name sortKey="Drag, Marcin" sort="Drag, Marcin" uniqKey="Drag M" first="Marcin" last="Drag">Marcin Drag</name>
<name sortKey="Kasperkiewicz, Paulina" sort="Kasperkiewicz, Paulina" uniqKey="Kasperkiewicz P" first="Paulina" last="Kasperkiewicz">Paulina Kasperkiewicz</name>
</country>
<country name="Pays-Bas"><region name="Hollande-Septentrionale"><name sortKey="Mulder, Monique P C" sort="Mulder, Monique P C" uniqKey="Mulder M" first="Monique P C" last="Mulder">Monique P C. Mulder</name>
</region>
<name sortKey="Ovaa, Huib" sort="Ovaa, Huib" uniqKey="Ovaa H" first="Huib" last="Ovaa">Huib Ovaa</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Ncbi/Merge

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001065 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 001065 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Ncbi
   |étape=   Merge
   |type=    RBID
   |clé=     pubmed:25764917
   |texte=   SARS hCoV papain-like protease is a unique Lys48 linkage-specific di-distributive deubiquitinating enzyme.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i   -Sk "pubmed:25764917" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a MersV1

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021

	Serveur d'exploration MERS
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration MERS

SARS hCoV papain-like protease is a unique Lys48 linkage-specific di-distributive deubiquitinating enzyme.

SARS hCoV papain-like protease is a unique Lys48 linkage-specific di-distributive deubiquitinating enzyme.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki